ArticleHypertension research : official journal of the Japanese Society of Hypertension2025
Response to the correspondence: Rethinking angiotensin receptor blocker (ARB) use in COVID-19: a class-wide call for careful dosing.
Fumiki YoshiharaPubMed ↗Publisher ↗
No numbers read from the abstract.